Independence Blue Cross to Cover MDxHealth Prostate Cancer Test
News Sep 29, 2016
MDxHealth SA has announced that Independence Blue Cross (Independence) has issued a positive medical coverage policy decision for the ConfirmMDx® for Prostate Cancer test. Independence Blue Cross is the leading health insurance organization in southeastern Pennsylvania. With its affiliates, Independence serves nearly 8.5 million people in 32 states and the District of Columbia, including more than 2.5 million in the region.
Independence is one of the 38 independent companies that form the Blue Cross and Blue Shield Association (BCBSA) that collectively cover more than 98 million people or 1 in 3 Americans. This positive policy decision for their commercial and Medicare lives represents the first BCBSA plan to establish coverage for ConfirmMDx for Prostate Cancer.
"This positive coverage decision by Independence Blue Cross is a significant milestone as we work towards achieving nationwide payer adoption of our ConfirmMDx for Prostate Cancer test," stated Dr. Jan Groen, CEO of MDxHealth. "This decision demonstrates that our investment in clinical studies and our work with managed care organisations in the US continues to yield positive results."
Tight junctions are multi-protein complexes that serve as barriers in epithelial tissues such as the skin or lining of the gut. Loss of a specific tight junction barrier protein, claudin 18, occurs in the majority of gastric cancer patients and is correlated with poor prognosis in patients with advanced gastric cancer.READ MORE